Butterfly Network Launches Proficiency Management Solution at American College of Emergency Physicians Scientific Assembly 2022

Butterfly, a digital health company transforming care through the power of handheld, whole-body ultrasound and connected medicine, today announced a new Proficiency Management Solution offered as part of its enterprise imaging platform, Butterfly Blueprint™. Shaped by insights from the emergency medicine community, which has been on the leading edge of utilizing point-of-care ultrasound (POCUS), Butterfly’s Proficiency Management Solution is designed to remove obstacles from standardizing ultrasound as core to “bedside” patient assessment, diagnosis, and treatment. The Butterfly Proficiency Management System addresses much of this and will foster adoption more broadly across Emergency Medicine and many other specialties.” Butterfly’s Proficiency Management Solution automates the management and analysis of ultrasound across an institution. “Our Proficiency Management tool aims to streamline this education, and ultimately, to accelerate the adoption and utilization of ultrasound information in patient assessment, diagnosis, and treatment.” The Company’s actual results may differ from its expectations, estimates, and projections and, consequently, you should not rely on these forward-looking statements as predictions of future events. These forward-looking statements include, without limitation, the Company’s expectations with respect to financial results, future performance, development of products and services, and the size and potential growth of current or future markets for its products and services.

Factors that may cause such differences include, but are not limited to: the impact of COVID-19 on the Company’s business, including issues relating to Omicron or other variants; the ability to recognize the anticipated benefits of the business combination; the Company’s ability to grow and manage growth profitably; the success, cost and timing of the Company’s product and service development activities; the potential attributes and benefits of the Company’s products and services; the degree to which our products and services are accepted by healthcare practitioners and patients for their approved uses; the Company’s ability to obtain and maintain regulatory approval for its products, and any related restrictions and limitations of any approved product; the Company’s ability to identify, in-license or acquire additional technology; the Company’s ability to maintain its existing license, manufacture, supply and distribution agreements; manufacturing and supply of the Company’s products; the Company’s ability to compete with other companies currently marketing or engaged in the development of products and services that the Company is currently marketing or developing; changes in applicable laws or regulations; the size and growth potential of the markets for the Company’s products and services, and its ability to serve those markets, either alone or in partnership with others; the pricing of the Company’s products and services and reimbursement for medical procedures conducted using its products and services; the Company’s estimates regarding expenses, revenue, capital requirements and needs for additional financing; the Company’s financial performance; the Company’s ability to raise financing in the future; and other risks and uncertainties indicated from time to time in the Company’s most recent Annual Report on Form 10-K or in subsequent filings that it makes with the Securities and Exchange Commission.